Secondary Fahr’s disease: A differential to be considered in a COVID-19 pneumonia patient with neuropsychiatric presentations

Felisitas Farica Sutantoyo, - and Paulus Sugianto, - (2021) Secondary Fahr’s disease: A differential to be considered in a COVID-19 pneumonia patient with neuropsychiatric presentations. Romanian JouRnal of neuRology, 20 (4). pp. 501-504. ISSN 1843-8148

[img] Text (Karil)
Karil 3.pdf

Download (1MB)
[img] Text (Bukti Korespondensi)
Bukti Korespondensi 3.PDF

Download (890kB)
[img] Text (Artikel)
Artikel 3.pdf

Download (3MB)
[img] Text (Similarity)
Similarity 3.pdf

Download (1MB)
Official URL: https://rjn.com.ro/articles/2021.4/RJN_2021_4_Art-...

Abstract

Background, aim. Fahr’s disease is a rare neurodegenerative disease caused by intracranial classifications. This case report aims to accentuate the importance of considering rare disease like Fahr’s disease as the differential diagnosis of neuropsychiatric deficits, especially in patients with a history of thyroidectomy. Case presentation. A 50-year-old female who underwent thyroidectomy 5 years previously presented with incoherent speech, behavioural problems, and hand stiffness. On evaluation, several neurobehavioral deficits and carpopedal spasms were observed, along with low Mini-Mental State Examination (MMSE), Hachinski, Activities of Daily Living (ADL), and Instrumental Activities of Daily Living Scale (IADL) score of 22, 4, 13, and 12, respectively. Clinically significant laboratory abnormalities include low serum calcium of 4.7 mg/dl, low thyroid stimulating hormone (TSH) level of 0.113 mIU/l, and low parathyroid hormone (PTH) level of 1.2 pg/ml. In addition, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reverse transcription-polymerase chain reaction (RT-PCR) test showed a positive result. Meanwhile, brain computerized tomography (CT)-scan results showed multiple bilateral calcifications in the basal ganglia, bilateral cortical-subcortical calcifications in the frontal lobe, and subcortical calcification in the left frontal lobe. Results. The patient was diagnosed with Fahr’s disease secondary to post-thyroidectomy hypoparathyroidism and coronavirus disease 2019 (COVID-19). The patient was treated with calcium lactate, levothyroxine, donepezil, favipiravir for COVID’s infection, vitamin B1, B6, and B12. Conclusions. Fahr’s disease should be considered in patients with neuropsychiatric deficits and spasm disorders, especially in patients with a history of thyroidectomy. Routine follow-up CT-scans after thyroidectomy are recommended.

Item Type: Article
Uncontrolled Keywords: basal ganglia calcification, Fahr’s disease, hypoparathyroidism
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
Divisions: 01. Fakultas Kedokteran > Ilmu Penyakit Saraf
Creators:
CreatorsNIM
Felisitas Farica Sutantoyo, -UNSPECIFIED
Paulus Sugianto, -NIDN8838700016
Depositing User: arys fk
Date Deposited: 09 Feb 2023 03:55
Last Modified: 09 Feb 2023 03:55
URI: http://repository.unair.ac.id/id/eprint/119907
Sosial Share:

Actions (login required)

View Item View Item